Drawing for BIRDZAI

USPTO serial 88775712

BIRDZAI

Reviewed by CopyMark Law Group

Reg. 6444006Status 700Renewal
Filing date
Status date
Registration date
Aug 10, 2021
Examiner
LARKEY, MICHAEL M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BIRDZAI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Erin C Bray

Erin C Bray TRADEMARK LAWYER LAW FIRM, PLLCP.O. BOX 512ANN ARBOR, MI 48106-0512United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software featuring computer software platforms for IT Solutions for Healthcare, Medical Devices, pharmaceutical and biotech industries, namely, Sales Force Automation to log interactions with health care professionals, patients, healthcare organizations including physicians, Patients, Payers, Providers, Customer Relationship Management application to manage Contacts, Accounts, Opportunities, Orders and other custom entities, Maintain operational customer master and integrate with other applications, Application to manage all phases of clinical trials including Site Management and Study Management, Application to provide patients with complete support during the course of therapy from the time of prescription including welcome call, Benefit Investigations, Trial Orders, Prior Authorization; downloadable Analytics and Planning software providing advanced analytics using machine learning, Internet of Things (IoT), and artificial intelligence to support interactions between pharma, biotech, and med devices companies, physicians, payers, and providersACTIVEJan 6, 2020
042Platform as a service (PAAS) featuring computer software platforms for IT Solutions for Healthcare, Medical Devices, pharmaceutical and biotech industries, namely, Mobile Application to Record Interactions with Healthcare Professionals, patients, healthcare organizations Including Physicians, Patients, Payers, Providers and Providing Representatives an Ability to View Media Content and Reports, Web and Mobile Portals For Patients to Find Information on Drugs and Connect with Pharma Companies, Web and Mobile Portals For Physicians to Find Information on Drugs and Connect with Pharma Companies, Mobile and Web Application to Providing Reporting and Analytics Capabilities Using Various Data Sources; Providing temporary use of non-downloadable cloud based software featuring computer software platforms for IT Solutions for Healthcare, Medical Devices pharmaceutical and biotech industries, namely, Sales Force Automation to log interactions with health care professionals including physicians, Patients, Payers, Providers, Customer Relationship Management application to manage Contacts, Accounts, Opportunities, Orders and other custom entities, Maintain operational customer master and integrate with other applications, Application to manage all phases of clinical trials including Site Management and Study Management, Application to provide patients with complete support during the course of therapy from the time of prescription including welcome call, Benefit Investigations, Trial Orders, Prior Authorization; Providing temporary use of online non-downloadable Analytics and Planning software providing advanced analytics using machine learning, Internet of Things (IoT), and artificial intelligence to support interactions between pharma, biotech, and med devices companies, physicians, payers, and providersACTIVEJan 6, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 10, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 25, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 25, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 25, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 25, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 25, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 10, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 27, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 27, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 27, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 25, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 25, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 5, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 19, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 12, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 12, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 8, 2021ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Feb 3, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Feb 3, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 3, 2021CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 14, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 14, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 7, 2021ALIEASSIGNED TO LIE—
Sep 29, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 3, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 3, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 3, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 16, 2020DOCKASSIGNED TO EXAMINER—
Feb 3, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 31, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance